Related Experiment Videos

Particulate contaminants of intravenous medications and infusions

Insights

Small volume parenteral medications contain significantly more particulate contamination than large volume infusions. For intensive care patients, intravenous drug administration contributes substantially to particle load, suggesting the need for in-line filtration.

Area of Science:

  • Pharmaceutical Science
  • Clinical Pharmacy
  • Medical Device Technology

Background:

  • Particulate contamination is a concern in intravenous therapies.
  • Parenteral medications are administered via small volume parenteral (SVP) and large volume infusion (LVI) routes.
  • The particle load from different administration routes requires comparative analysis.

Purpose of the Study:

  • To compare particulate contamination levels in SVP medications versus LVI fluids.
  • To assess the contribution of intravenous medications to the total particle load in intensive care patients.
  • To provide recommendations for mitigating particle exposure during intravenous drug administration.

Main Methods:

  • Particle counts were determined for 39 SVP medications and 7 LVI fluids.
  • Automated light blockage (HIAC) and optical microscopy were employed for particle analysis.
  • A random survey of drug therapy in intensive care unit (ICU) patients was conducted.

Main Results:

  • SVP medications exhibited higher particulate contamination compared to LVI fluids.
  • Intravenous medications were found to be a major contributor to the total particle load in ICU patients.
  • The particle load from drug therapy significantly exceeded that from infusion fluids.

Conclusions:

  • Intravenous medications contribute substantially more to patient particle load than infusion fluids.
  • Final in-line filtration proximal to the cannula should be considered for intravenous drug administration.
  • Further research on the systemic effects of drug particles and regulatory adjustments are warranted.

Related Concept Videos